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Invariant NK T cells (iNKT cells) recognize 
microbial and endogenous cellular lipid anti-
gens presented by CD1d molecules (Brigl and 
Brenner,  2004;  Kronenberg,  2005;  Bendelac   
et al., 2007). iNKT cells express an invariant 
TCR- chain (V14J18 in mice and  V24J18 
in humans) paired with a limited set of TCR- 
chains, display surface receptors typically found 
on NK cells, and have a memory/effector phe-
notype in the absence of prior stimulation 
(Godfrey et al., 2004). iNKT cells constitutively 
express  mRNA,  but  not  protein,  for  IFN-, 
poising them for rapid effector function (Stetson 
et  al.,  2003). Together,  these  features  distin-
guish iNKT cells from MHC-restricted T cells 
and suggest distinct modalities of activation.   
A growing body of evidence documents a criti-
cal role for iNKT cells during bacterial, viral, 
fungal, and protozoan infections (Tupin et al., 
2007; Cohen et al., 2009). The protective, and 
in some instances detrimental, functions of 
iNKT cells during infection are often the re-
sult of their ability to rapidly produce copious 
amounts of IFN- and to contribute to the re-
cruitment and activation of other cell types, 
including neutrophils, macrophages, DCs, NK 
cells, and B cells. These properties enable iNKT 
cells to orchestrate and amplify the protective im-
mune response to infection (Brigl and Brenner, 
2004; Tupin et al., 2007; Cohen et al., 2009).   
Yet how CD1d-restricted iNKT cells, with their 
limited TCR diversity, become activated rapidly 
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Invariant natural killer T cells (iNKT cells) are critical for host defense against a variety of 
microbial pathogens. However, the central question of how iNKT cells are activated by mi-
crobes has not been fully explained. The example of adaptive MHC-restricted T cells, studies 
using synthetic pharmacological -galactosylceramides, and the recent discovery of microbial 
iNKT cell ligands have all suggested that recognition of foreign lipid antigens is the main 
driver for iNKT cell activation during infection. However, when we compared the role of 
microbial antigens versus innate cytokine-driven mechanisms, we found that iNKT cell  
interferon- production after in vitro stimulation or infection with diverse bacteria over-
whelmingly depended on toll-like receptor–driven IL-12. Importantly, activation of iNKT cells 
in vivo during infection with Sphingomonas yanoikuyae or Streptococcus pneumoniae, patho-
gens which are known to express iNKT cell antigens and which require iNKT cells for effective 
protection, also predominantly depended on IL-12. Constitutive expression of high levels of 
IL-12 receptor by iNKT cells enabled instant IL-12–induced STAT4 activation, demonstrating 
that among T cells, iNKT cells are uniquely equipped for immediate, cytokine-driven activa-
tion. These findings reveal that innate and cytokine-driven signals, rather than cognate 
microbial antigen, dominate in iNKT cell activation during microbial infections.
© 2011 Brigl et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the   
publication date (see http://www.rupress.org/terms). After six months it is available 
under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Un-
ported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e1164 Innate iNKT cell activation during infection | Brigl et al.
NK cells and the systemic release of IFN- after iNKT 
cell stimulation (Kitamura et al., 1999; Kawakami et al., 
2001; Matsuda et al., 2003).
In contrast to the TCR-mediated recognition of 
microbial lipid antigens, iNKT cells can be activated 
fully in response to microbial products by an innate 
cytokine-  and  self-antigen–driven  pathway.  In  this 
scenario, iNKT cell activation results from combined 
stimulation with a weak TCR-mediated signal from 
recognition  of  endogenous  CD1d-presented  lipids, 
together with cytokine-mediated co-stimulation by IL-12, re-
leased by DCs after toll-like receptor (TLR)–mediated activa-
tion (Brigl et al., 2003; Mattner et al., 2005; Nagarajan and 
Kronenberg, 2007). iNKT cell activation after stimulation of 
DCs with TLR agonists can be modulated by alterations in 
CD1d-presented self-lipids and changes in CD1d expression 
levels (Sköld et al., 2005; Raghuraman et al., 2006; Paget et al., 
2007; Salio et al., 2007). In some cases, such as stimulation with 
LPS from Escherichia coli or during viral infection, iNKT cell 
activation can be so dominantly driven by IL-12 and IL-18 
that very little or no TCR-mediated stimulation by CD1d- 
presented  self-lipids  is  needed  (Nagarajan  and  Kronenberg, 
2007; Tyznik et al., 2008; Wesley et al., 2008). This innate 
cytokine-driven pathway of activation allows iNKT cell recog-
nition of pathogens that express TLR ligands but appear to lack 
CD1d-presented lipid antigens, such as viruses or the Gram-
negative bacterium Salmonella typhimurium (Brigl et al., 2003; 
Mattner et al., 2005; Tyznik et al., 2008; Wesley et al., 2008).
The current model suggests that, dependent on the expres-
sion of antigens by the microbe, iNKT cell activation during 
microbial infection is cognate, foreign antigen driven, or in-
nate cytokine driven (Mattner et al., 2005; Tupin et al., 2007; 
in response to vastly diverse microbial infections remains in-
completely understood.
Two distinct pathways have been described for iNKT cell 
activation during microbial infection. The microbial antigen-
driven pathway involves direct recognition of CD1d-presented 
microbial  lipid  antigens  by  iNKT  cells.  Glycosphingolipids 
(GSLs) found in Sphingomonas spp. (Kinjo et al., 2005; Mattner   
et al., 2005; Sriram et al., 2005) and diacylglycerols isolated from 
both Borrelia burgdorferi (Kinjo et al., 2006) and Streptococcus pneu-
moniae (Burrows et al., 2009) can be presented by CD1d mole-
cules, and these microbial lipid antigens have been proposed to 
drive iNKT cell activation in a TCR-dependent manner during 
infection (Kinjo et al., 2005, 2006; Mattner et al., 2005). After ex-
posure to these microbial antigens, iNKT cells produce both 
IFN- and IL-4 within hours (Kinjo et al., 2005, 2006; Mattner 
et al., 2005). The recognition of microbial glycosylceramides by 
iNKT cells has been proposed to fill a gap in the innate recogni-
tion of Gram-negative LPS-negative -proteobacteria such as 
Sphingomonas spp. and Ehrlichia spp. (Kinjo et al., 2005; Mattner   
et al., 2005). The production of IFN- by iNKT cells in response 
to antigen stimulation does not require IL-12 signaling; however, 
IL-12 is known to play a critical role in the trans-activation of 
Figure 1.  Antigen- versus cytokine-driven pathways of 
iNKT cell activation. (A–C) iNKT cell lines were cultured with 
WT (filled squares) and CD1d-deficient (A), MyD88-deficient  
(B), or IL-12p35–deficient (C; all open squares) BM-derived DCs 
and stimulated with various concentrations of LPS, CpG, or 
GSL-1 for 16–24 h. Cytokine concentrations in culture superna-
tants were measured by ELISA. Data are presented as means of 
duplicate values ± SD and are representative of at least three 
independent experiments. Bar graphs show percent inhibition 
of IFN- secretion in culture supernatants comparing CD1d-
deficient (A), MyD88-deficient (B), or IL-12p35-deficient (C) DCs 
(filled bars) to WT DCs after stimulation with 2 ng/ml LPS, 2 µg/ml 
CpG, or 10 µg/ml GSL-1, and data are summarized from four 
independent experiments (mean ± SD). Open bars in C repre-
sent the percentage of IFN- secretion in the presence of  
10 µg/ml of blocking anti–IL-12 antibodies. Data are summarized 
from two independent experiments. No significant inhibition 
was observed with control antibodies (not depicted). (D and  
E) Experiments showing IL-4 production in response to GSL-1, 
LPS, or CpG using CD1d- (D) and MyD88- and IL-12–deficient 
(E) BM DCs were performed as in A–C. IL-4 concentrations in 
culture supernatants were measured by ELISA. n.a. indicates not 
applicable because IL-4 levels with WT DCs were very low. Data 
are presented as means of duplicate values ± SD and are repre-
sentative of at least three independent experiments.JEM Vol. 208, No. 6 
Article
1165
IFN- (Fig. 1 A, left). This IFN- response was dependent on 
recognition of CD1d by iNKT cell lines, as use of CD1d- 
deficient DCs resulted in markedly reduced IFN- secretion 
(Fig. 1 A). To determine the requirement for TLR- and cyto-
kine-mediated stimulation for the activation of iNKT cell 
lines, we performed experiments using DCs deficient in the 
adaptor protein MyD88 or the production of IL-12, as well as 
blocking antibodies against IL-12. Stimulation of iNKT cell 
lines with GSL-1 was not altered when DCs deficient in 
MyD88 were used (Fig. 1 B) and was only marginally re-
duced when IL-12–deficient DCs were used or when mAbs 
to IL-12 were added to the cultures (Fig. 1 C). Thus, iNKT 
cell activation by a microbial lipid antigen required CD1d 
expression and was essentially independent of TLR signal-
ing or IL-12 production by APCs. The slightly reduced 
iNKT cell IFN- response to GSL-1 in the presence of IL-12–
deficient DCs or after addition of mAb against IL-12 was 
likely the result of a lack of IL-12–mediated amplification   
of iNKT cell IFN- production that has been noted after 
CD40L-mediated stimulation of DCs by antigen-activated 
iNKT cells (Tomura et al., 1999).
In contrast to their direct stimulation by CD1d-presented 
microbial lipid antigens, iNKT cells can also be stimulated 
with TLR agonists in the presence of DCs by a self-antigen– 
and cytokine-driven pathway that does not require the cognate 
recognition of microbial antigens by iNKT cells (Brigl et al., 
2003; Nagarajan and Kronenberg, 2007; Paget et al., 2007; 
Salio et al., 2007). Indeed, iNKT cell lines incubated with 
WT DCs and stimulated with the TLR agonists LPS (TLR4) 
or CpG (TLR9) produced copious amounts of IFN- (Fig. 1 A, 
second and third panel). To determine the requirements for a 
Brigl and Brenner, 2010). In this paper, we investigated the 
relative contributions of microbial antigen– versus cytokine-
driven pathways in iNKT cell activation using a large panel 
of diverse bacterial pathogens, several of which are known 
to express iNKT cell antigens and/or have been shown to 
require iNKT cells for protective immunity. Unexpectedly, 
we found that iNKT cell IFN- production was dominantly 
dependent on innate mechanisms with TLR-mediated sig-
naling and the production of IL-12 by APCs, irrespective of 
whether or not bacteria express CD1d-presented iNKT cell 
antigens. Furthermore, high levels of IL-12 receptor were ex-
pressed by iNKT cells, readying them for rapid cytokine- 
mediated stimulation. Thus, our data suggest that innate 
signals, together with cytokine-driven activation, are the 
dominant pathway enabling rapid iNKT cell responses to di-
verse microbial infections.
RESULTS
Antigen- and cytokine-driven pathways of iNKT  
cell activation
Studies using only NKT cell hybridomas do not adequately 
model the NKT cell activation mechanism that may occur in 
vivo because such systems lack the potential to respond to 
both antigen and cytokine signals. To investigate the mecha-
nisms of iNKT cell activation by microbes, we used a system 
with primary mouse iNKT cell lines and BM-derived DCs 
that is able to respond to a variety of stimuli (Chiba et al., 
2009). iNKT cell lines incubated with DCs and stimulated 
with the CD1d-presented microbial GSL antigen GSL-1, which 
is found in Sphingomonas spp. (Kinjo et al., 2005; Mattner   
et al., 2005; Sriram et al., 2005), produced large amounts of 
Table I.  Bacteria used in this study
Organism Strain Antigens Role of iNKT in infection Reference
Gram-positive
S. pneumoniae URF918 GlcDAG, GalGlcDAG Protective Burrows et al., 2009; Kawakami et al., 2003
L. monocytogenes 10403S N.d. Protective Arrunategui-Correa and Kim, 2004
S. aureus 25923a N.d. N.d. Brigl et al., 2003
Gram-negative
P. aeruginosa D4 N.d. Protective Nieuwenhuis et al., 2002
S. typhimurium MT110 N.d. Not protective Berntman et al., 2005; Brigl et al., 2003
E. coli 25922a N.d. N.d.
-Proteobacteria
S. capsulata 14666a GSL-1 (GlcAGSL) Protective Mattner et al., 2005
N. aromaticivorans 700278a GSL-1 Induction of PBC Mattner et al., 2008
S. yanoikuyae 51230a GSL-1 Protective Kinjo et al., 2005
Spirochetes
B. burgdorferi N40 BbGL-II (GalDAG) Protective Kinjo et al., 2006; Kumar et al., 2000; Tupin et al., 2008
Mycobacteria
M. tuberculosis H37Rv PIM4
b Not protective Behar et al., 1999; Fischer et al., 2004
Description of bacteria used in this study, microbial lipid antigens, if any, described for the respective bacterium, and role of iNKT cells during infection.  
GlcAGSL, glucuronic acid containing GSL; BbGL-II, B. burgdorferi glycolipid II; GalDAG, galactosyl diacylglycerol; PIM4, phosphatidylinositol mannoside 4; N.d., not described; 
PBC, primary biliary cirrhosis.
aAmerican Type Culture Collection number.
bAntigenic activity of this lipid could not be confirmed by some investigators (Kinjo et al., 2006).1166 Innate iNKT cell activation during infection | Brigl et al.
DCs, TLR agonist–induced IFN- production by iNKT cell 
lines was significantly reduced in response to LPS or CpG, 
respectively, compared with stimulation in the presence of 
WT DCs (Fig. 1 A). Because no exogenous microbial antigens 
CD1d–TCR interaction, TLR signaling, and IL-12 stimula-
tion after activation of iNKT cells with TLR agonists, we 
used DCs from CD1d-, MyD88-, or IL-12–deficient mice 
and blocking antibodies against IL-12. Using CD1d-deficient 
Figure 2.  Detection of microbial lipid antigens expressed by bacteria. Lipids were extracted from bacteria and analyzed by ESI mass spectrometry. 
(A–C) [M – H] adducts of the GSL-1 (GlcAGSL) antigen in S. capsulata, N. aromaticivorans, and S. yanoikuyae. (D) [M + CH3COO] adducts of the GalDAG 
(BbGL-II) antigen in B. burgdorferi. (E) [M + Na]+ adducts of the GlcDAG and GalGlcDAG antigens in S. pneumoniae. For annotation of sphingosine and 
acyl chain composition see Table S1. For corresponding LC and MS data of lipid antigens expressed by bacteria see SI Fig. 1.JEM Vol. 208, No. 6 
Article
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were present under these conditions, recognition of CD1d-
presented cellular self-antigens appeared to be required for 
iNKT cell activation, as has been previously noted (Brigl   
et al., 2003). When MyD88-deficient DCs were used during 
stimulation of iNKT cell lines, IFN- production in response 
to LPS or CpG was markedly reduced (Fig. 1 B). Further-
more, iNKT cell activation in response to LPS or CpG was 
strikingly reduced when DCs deficient in IL-12 production 
were used and when mAb to IL-12 was added to the cultures 
(Fig. 1 C). In response to antigens, iNKT cells are also known 
to secrete IL-4. After stimulation with GSL-1, iNKT cell 
lines produced IL-4 in a CD1d-dependent and MyD88- and 
IL-12–independent manner (Fig. 1, D and E). In re-
sponse to LPS or CpG, no significant amounts of 
IL-4 were detected (Fig. 1, D and E). Thus, TLR   
agonist–induced IFN- secretion by iNKT cell lines 
in the presence of DCs was driven by recognition of 
CD1d-presented self-antigens and IL-12, which are 
produced by APCs after TLR-mediated activation, 
whereas antigen-driven activation results in TLR- 
and IL-12–independent IFN- and IL-4 secretion.
Expression of microbial iNKT cell antigens
To examine the mechanism of iNKT cell activation 
in response to bacterial infection, we assembled a 
panel of 11 bacteria, 5 of which are known to ex-
press CD1d-presented iNKT cell antigens (Table I). 
The diverse panel of bacteria was selected to include 
clinically important pathogens such as the Gram-
positive bacteria S. pneumoniae, Listeria monocytogenes 
and Staphylococcus aureus, the Gram-negative bacteria 
Pseudomonas aeruginosa, S. typhimurium, and E. coli,   
the  spirochete  B.  burgdorferi,  the  mycobacterium   
Mycobacterium tuberculosis, and the -proteobacteria 
Sphingomonas capsulata, Novosphingobium aromaticivorans, 
and Sphingomonas yanoikuyae. Members of the class 
of -proteobacteria are known to cause opportunis-
tic infections in humans and have been associated 
with the induction of autoimmunity (Mohammed 
and Mattner, 2009; Ryan and Adley, 2010). Further-
more, iNKT cells are critical in mice for protective 
immunity to infection with S. pneumoniae, B. burgdorferi, 
P . aeruginosa, S. capsulata, and L. monocytogenes, and 
iNKT cells have been implicated in the develop-
ment of primary biliary cirrhosis in a mouse model   
after infection with N. aromaticivorans (see Table I for 
summary and references).
From  among  the  panel  of  bacteria,  microbial 
CD1d-presented lipid antigens that are capable of stimulating 
iNKT cells have been described for S. capsulata, N. aromaticivorans, 
and S. yanoikuyae (all three GSL-1), B. burgdorferi (BbGL-II), and 
S.  pneumoniae  (monoglycosyl-  and  diglycosyldiacylglycerol; 
for details and references see Table I). To confirm that bacte-
ria used in this study indeed expressed iNKT cell antigens, 
we isolated polar lipids from S. capsulata, N. aromaticivorans,   
S. yanoikuyae, B. burgdorferi, and S. pneumoniae and sub-
jected the lipids to electrospray mass spectrometry analysis. 
Lipids from S. capsulata, N. aromaticivorans, and S. yanoikuyae 
yielded ions representing the [M – H] ions of the antigenic 
-glucuronosylceramide GSL-1 (Fig. 2, A–C; and Table S1). 
Figure 3.  Cytokine responses of iNKT cells to diverse 
bacteria. iNKT cell lines were cultured with WT (filled squares) 
or CD1d-deficient (open squares) DCs in the presence of heat-
inactivated bacteria. (A and B) IFN- (A) and IL-4 (B) concen-
trations were measured in culture supernatants by ELISA after 
16–24 h. Data represent means of duplicate values ± SD and 
are representative of at least three independent experiments.1168 Innate iNKT cell activation during infection | Brigl et al.
Mechanism of bacteria-induced iNKT cell activation
We next examined the mechanism of iNKT cell activation in 
response to the 11 bacteria described in the previous section. 
iNKT cell lines incubated with WT DCs and stimulated with 
any  of  the  11  heat-killed  bacteria  produced  substantial 
amounts of IFN- (Fig. 3 A). iNKT cell activation induced 
by heat-killed bacteria required a CD1d-TCR interaction, as 
IFN-  production  by  iNKT  cell  lines  in  the  presence  of 
CD1d-deficient DCs and any of the 11 heat-killed bacteria 
was reduced by a mean of 50–80%, compared with stimula-
tion in the presence of WT DCs (Fig. 3 A). Little or no IL-4 
was generated by iNKT cells after stimulation with most of 
the heat-killed bacteria, whereas stimulation with B. burgdor-
feri, S. capsulata, N. aromaticivorans, and S. yanoikuyae resulted in 
production of low amounts of IL-4 (Fig. 3 B and not depicted). 
The amounts of IL-4 detectable in culture supernatants var-
ied substantially between experiments and were generally re-
duced after repeated stimulation of iNKT cell lines, and no 
For  B.  burgdorferi  lipids,  ions  corresponding  to  the  [M  + 
CH3COO] adduct ions of -galactosyldiacylglycerol, the 
BbGL-II antigen, were detected (Fig. 2 D and Table S1). In 
positive-ion mode, the lipids from S. pneumoniae gave rise to 
[M + Na]+ ions corresponding to the -glucosyldiacylglycerol 
(GlcDAG), together with ions corresponding to the –galactosyl 
GlcDAG (GalGlcDAG; Fig. 2 E and Table S1). The structural 
assignments for individual lipid species were supported by 
multiple-stage ion-trap tandem mass spectrometry (Table S1 
and not depicted). Further analysis of the bacterial lipids by 
liquid chromatography, light scattering detection, and mass 
spectrometry analysis confirmed the presence of the respec-
tive antigenic lipid species in these five bacteria and suggested 
that all bacteria expressed significant amounts of the respec-
tive antigens (Fig. S1). Thus, 5 of the 11 bacteria used in this 
study expressed known iNKT cell lipid antigen species as ex-
pected. No lipids capable of stimulating iNKT cells directly 
have so far been described for the other 6 bacteria.
Figure 4.  Mechanism of iNKT cell activation in 
response to diverse bacteria (A) iNKT cell lines were 
cultured with WT or MyD88-deficient DCs in the 
presence of heat-inactivated bacteria. Data for IFN- 
secretion in culture supernatants are shown as per-
cent inhibition comparing MyD88-deficient to WT 
DCs after stimulation with 10 bacteria per DC for  
E. coli (Ec), P. aeruginosa (Pa), and S. typhimurium (St) 
and with 100 bacteria per DC for S. pneumoniae (Sp), 
L. monocytogenes (Lm), S. aureus (Sa), B. burgdorferi 
(Bb), S. capsulata (Sc), N. aromoticivorans (Na),  
S.yanoikuyae (Sy), and M. tuberculosis (Mt). Data are 
summarized from four independent experiments 
(mean ± SD). (B) Concentration of IL-12p40 (ng/ml, 
filled bars) and IL-12p70 (pg/ml, open bars) measured 
by ELISA in culture supernatants of DCs stimulated 
with microbial products or heat-killed bacteria as in 
Fig. 1 and Fig. 4 A, respectively (mean ± SD). No IL-18 
was detected in culture supernatants and IFN- con-
centrations were not different between unstimulated 
and stimulated conditions (not depicted). (C) iNKT cell 
lines were cultured with WT or IL-12p35–deficient 
DCs in the presence of stimuli as described in A. Data 
are shown as percentage of IFN- secretion in cul-
ture supernatants comparing IL-12–deficient to  
WT DCs after stimulation (filled bars; mean ± SD). 
Open bars represent the percentage of IFN- secretion 
in the presence of 10 µg/ml blocking mAb against IL-12. 
No significant inhibition was observed with isotype-
matched control antibodies (not depicted). Data are 
summarized from two independent experiments.  
(D) Expression of the early activation marker CD25 by 
iNKT cells after 24 h of co-culture with WT or IL-12–
deficient DCs in the presence of stimuli as in A. GSL-1 
was used at 2 µg/ml, LPS at 10 ng/ml, and CpG at  
2 µg/ml. (E) IL-4 production by iNKT cells in response 
to heat-inactivated bacteria using WT (filled squares), 
MyD88-deficient (open squares), or IL-12–deficient 
(open circles) DCs. Experiments were performed as in 
Fig. 1 (D and E). IL-4 concentrations in culture supernatants were measured by ELISA. Data are presented as means of duplicate values ± SD and are rep-
resentative of at least three independent experiments.JEM Vol. 208, No. 6 
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obtained for the early activation marker CD69 (unpublished 
data). iNKT cell IFN- production and CD25 expression 
were also both reduced on day 2 after stimulation with anti-
gen, TLR  agonists,  or  heat-killed  bacteria,  suggesting  that 
iNKT cell activation in the absence of IL-12 was not delayed 
(Fig. S5, A and B). The weak IL-4 responses observed after 
significant amounts of IL-4 were detected with iNKT cells 
isolated directly from V14 TCR transgenic mice (unpub-
lished data).
Next, we determined if iNKT cell activation by heat-
killed bacteria required TLR-mediated signaling by the APCs. 
iNKT cell lines incubated with MyD88-deficient DCs plus 
any of the 11 heat-killed bacteria resulted in reduced IFN- 
secretion when compared with WT DCs (Fig. 4 A and Fig. S2). 
Thus, whether the bacteria used for stimulation expressed 
known microbial lipid antigens, iNKT cell IFN- secretion 
was critically dependent on TLR-mediated signaling by DCs. 
This result suggested that iNKT cell activation in response to 
bacteria expressing microbial iNKT cell antigens might not 
be mediated by TCR recognition of the microbial lipid anti-
gens and instead might be cytokine-driven.
IL-12, IL-18, and type I IFNs have been implicated in ac-
tivating iNKT cells after TLR-mediated stimulation of DCs 
in the absence of iNKT cell recognition of CD1d-presented 
microbial lipid antigens (Brigl et al., 2003; Mattner et al., 
2005; Nagarajan and Kronenberg, 2007; Paget et al., 2007; 
Salio et al., 2007). We determined if any of these cytokines 
were generated by DCs after stimulation with the panel of 
heat-killed bacteria by measuring the concentration of IL-12, 
IL-18, and IFN- in supernatants from DCs cultured with 
TLR agonist, GSL-1, or any of the 11 heat-killed bacteria. 
Significant quantities of IL-12p40 and IL-12p70, but not of 
IL-18 or IFN-, were detected in supernatants of DCs exposed 
to LPS, CpG, or any of the 11 heat-killed bacteria (Fig. 4 B 
and not depicted). In contrast, no IL-12p40 or IL-12p70 was 
detected in supernatants of DCs cultured in the presence of 
the GSL-1 antigen. Then, we determined whether IL-12 was 
required for IFN- secretion by iNKT cell lines in response 
to stimulation with heat-killed bacteria. Indeed, incubation of 
iNKT cell lines with IL-12–deficient DCs in the presence of 
any of the 11 heat-killed bacteria resulted in substantially re-
duced IFN- production compared with stimulation in the 
presence of WT DCs (Fig. 4 C and Fig. S2). Similarly, addition 
of blocking mAb against IL-12 reduced iNKT cell IFN- se-
cretion after stimulation with any of the 11 heat-killed bacte-
ria (Fig. 4 C). In contrast, stimulation of iNKT cell lines with 
IL-18–deficient DCs or after stimulation of iNKT cell/DC 
co-cultures in the presence of antibodies blocking type I IFN 
signaling did not show a requirement for IL-18 or type I 
IFNs, respectively, in response to any of the 11 heat-killed 
bacteria (Fig. S3, A and B). As described, MyD88- and IL-12–
deficient DCs were capable of presenting the purified GSL-1 
antigen to stimulate iNKT cell lines but were not capable of 
eliciting IFN- secretion by iNKT cell lines in response to 
the TLR agonists LPS and CpG (Fig. 1). We next determined 
if expression of the early activation marker CD25 on iNKT 
cells after stimulation was dependent on IL-12. Expression 
levels of CD25 were increased after stimulation with GSL-1, 
TLR agonists, or heat-killed bacteria (Fig. 4 D and Fig. S4). 
Stimulation with TLR agonists or heat-killed bacteria, but 
not with GSL-1, resulted in decreased expression on CD25 
when DCs deficient in IL-12 were used. Similar results were 
Figure 5.  iNKT cell response to live in vitro infection. DCs were in-
cubated with 2 µg/ml CpG, 10 µg/ml GSL-1, P. aeruginosas, S. typhimurium 
(both 10 live bacteria per DC), L. monocytogenes, B. burgdorferi, S. capsu-
lata, or N. aromaticivorans (all 100 live bacteria per DC) for 3 h, followed 
by washing and plating with iNKT cell lines. (A and B) IFN- (A) or IL-4  
(B) concentrations were measured in culture supernatants by ELISA after 
16–24 h. Data are displayed as means of triplicate measurements ± SD and 
are representative of at least two independent experiments.1170 Innate iNKT cell activation during infection | Brigl et al.
irrespective of the expression of iNKT cell antigens by the 
bacteria. This suggested that iNKT cell activation in response 
to infected DCs was dominantly cytokine driven and that 
TLR-mediated signals were required, whereas CD1d-mediated 
signals played a variable role.
In vivo activation of iNKT cells  
during Sphingomonas infection
Next, we analyzed iNKT cell activation in a mouse model of 
Sphingomonas infection. Mononuclear cells were isolated from 
stimulation  with  Borrelia  and  Sphingomonas  spp.  showed  a 
trend  toward  being  reduced  when  MyD88-deficient  DCs 
were used and toward being increased when IL-12–deficient 
DCs were used (Fig. 4 E). iNKT cells freshly isolated from 
WT mice by tetramer sorting also showed a strong depen-
dence of the iNKT cell IFN- production on MyD88 and 
IL-12, whereas little or no IL-4 was generated (Fig. S6, A and B). 
The  CD1d-dependence  of TLR  agonist-  and  bacteria- 
induced activation of freshly isolated iNKT cell was reduced 
compared with what was observed using iNKT cell lines, 
which is likely the result of stimulation of iNKT cells using 
TCR- antibodies and tetramer for their purification by cell 
sorting, as has been observed previously (Matsuda et al., 2003; 
Nagarajan and Kronenberg, 2007).
To determine if alterations in CD1d expression levels by 
the APCs may contribute to the observed iNKT cell activa-
tion, CD1d expression levels were determined on WT DCs 
after exposure to heat-killed bacteria. Stimulation with the 
TLR agonists LPS and CpG and all 11 of the heat-killed bac-
teria, but not GSL-1, resulted in increased expression of CD1d 
by DCs (Fig. S7, A and B). The increased expression of 
CD1d after stimulation was absent in the presence of MyD88-
deficient DCs, suggesting that TLR-mediated signaling was 
required. Thus, iNKT cell activation by a wide variety of 
heat-killed  bacterial  pathogens  in  vitro,  including  bacteria 
which expressed CD1d-presented microbial lipid antigens, 
such as Sphingomonas spp., B. burgdorferi, M. tuberculosis, or S. 
pneumoniae, was dominantly dependent on TLR signaling and 
IL-12–driven stimulation.
iNKT cell activation after live in vitro infection
To further investigate the mechanism of iNKT cell activation 
in response to DCs infected with live bacteria, we used an   
in vitro live infection model with three microorganisms shown 
to express iNKT cell antigens (B. burgdorferi, S. capsulata, and 
N. aromaticivorans; Table I) and three microorganisms for which 
iNKT cell antigens have not been described (P . aeruginosa,   
S. typhimurium, and L. monocytogenes). DCs were infected with 
bacteria for 3 h and infected DCs were then co-cultured with 
iNKT cell lines, resulting in production of substantial amounts 
of IFN- for all six bacteria tested (Fig. 5 A). To determine 
the relative requirements for a CD1d–TCR interaction, TLR 
signaling, and IL-12 stimulation after activation of iNKT cells 
with infected DCs, we used DCs from CD1d-, MyD88-, or 
IL-12–deficient mice. Infection of DCs deficient in CD1d, 
MyD88, or IL-12 production with P . aeruginosa, S. typhimurium, 
L. monocytogenes, B. burgdorferi, S. capsulata, or N. aromaticivorans 
resulted in reduced IFN- production by iNKT cell lines, 
compared with infection of WT DCs (Fig. 5 A). Live in vitro 
infection with B. burgdorferi, and to a lesser extent S. capsulata, 
resulted in the production of IL-4 (Fig. 5 B). This IL-4 pro-
duction was largely MyD88 dependent but IL-12 indepen-
dent. Thus, similar to the results obtained after stimulation 
with heat-killed bacteria, iNKT cell IFN- production in re-
sponse to DCs infected with live bacteria was dependent 
on CD1d recognition, TLR-signaling, and IL-12 stimulation, 
Figure 6.  In vivo activation of iNKT cells during S. yanoikuyae  
infection. (A) CD69 surface staining on CD1d tetramer–positive iNKT cells 
isolated from the livers of uninfected WT mice (dotted line) or 18 h after i.v. 
infection with S. yanoikuyae (bold line). (B) IFN- secretion by CD1d tetra-
mer–positive liver iNKT cells from uninfected animals (left, bold line) or 18 h 
after i.v. infection with S. yanoikuyae (right, bold line) in comparison with 
staining with isotype control antibodies (dotted line). (C and D) Comparison 
of IFN- secretion (C) and CD69 expression (D) by CD1d tetramer–positive 
liver iNKT cells in WT and IL-12–deficient mice 18 h after i.v. infection with 
S. yanoikuyae (mean ± SD). (E) WT or IL-12-deficient mice were injected i.v. 
with 20, 5, or 1.25 µg GSL-1, and IFN- secretion by CD1d tetramer– 
positive liver iNKT cells was determined after 80 min. Means ± SD are 
shown. Data are pooled from three independent experiments and represent 
four to six mice per condition. (F) IL-4 secretion by liver iNKT cells 45 min 
after injection of 2 µg -GalCer. Similar results were observed with GSL-1 
(not depicted). (G) IL-4 secretion by liver iNKT cells from uninfected animals 
or 18 h after i.v. infection with S. yanoikuyae in comparison with staining 
with isotype control antibodies. Data are representative of two independent 
experiments using three to four mice per condition.JEM Vol. 208, No. 6 
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Thus, iNKT cells became activated rapidly after S. pneumoniae 
infection. Cytokine secretion assays showed significant IFN- 
secretion by iNKT cells on days 2 and 4 after infection that 
returned to baseline by day 7 after infection (Fig. 7 D). No 
significant production of IL-4 by iNKT cells was observed in 
either WT or IL-12–deficient mice during infection at any of 
the time points examined (Fig. 7 D and not depicted). Thus, 
iNKT cells became activated rapidly and expressed IFN- 
early during pulmonary infection with S. pneumoniae.
Next, we determined whether IL-12 was required for the 
activation of iNKT cells during S. pneumoniae infection, as 
was the case in the in vitro experiments described in the pre-
vious paragraphs. IL-12 deficiency resulted in reduced IFN- 
secretion and CD69 expression on days 2 and 4 after infection 
WT mice 18 h after intravenous infection with S. yanoikuyae 
and iNKT cells were identified using CD1d tetramers. CD1d 
tetramer–positive iNKT cells from livers of uninfected mice 
stained  at  intermediate  intensity  for  the  early  activation 
marker CD69 (mean fluorescence intensity [MFI], 465 ± 13) 
and, 18 h after infection, expression of CD69 increased to an 
MFI of 2,990 ± 639 (Fig. 6 A). IFN- secretion by iNKT 
cells showed that a mean of 41 ± 14% of the CD1d tetramer–
positive iNKT cells were positive 18 h after infection, compared 
with a mean of 2 ± 0.1% in uninfected controls (Fig. 6 B). 
Thus, iNKT cells became rapidly activated after S. yanoikuyae 
infection. To assess whether IL-12 was required for the in vivo 
activation of iNKT cells during S. yanoikuyae infection, as 
suggested by our in vitro experiments, we compared IFN- 
secretion and CD69 expression by liver iNKT cells in WT 
versus IL-12–deficient mice after infection. 18 h after infec-
tion, IL-12 deficiency resulted in reduced IFN- secretion 
and CD69 expression (Fig. 6, C and D).
To compare the requirement for IL-12 in iNKT cell IFN- 
secretion after infection with S. yanoikuyae bacteria that 
express the GSL-1 antigen with iNKT cell activation induced 
by the GSL-1 antigen, we analyzed iNKT cell activation after 
stimulation with purified GSL-1 antigen. After injection of a 
range of doses of GSL-1 antigen, IFN- secretion by CD1d 
tetramer–positive liver iNKT cells was similar in WT or   
IL-12–deficient mice (Fig. 6 E). IL-4 production by iNKT 
cell  in  vivo  was  readily  observed  after  injection  of  the   
-galactosylceramide (GalCer) antigen; however, during infec-
tion with S. yanoikuyae, S. capsulata, or N. aromaticivorans no sig-
nificant amounts of IL-4 were detected in either WT or 
IL-12–deficient mice (Fig. 6, F and G; and not depicted). Thus, 
iNKT cell activation after infection with a GSL-1–expressing 
microbe is dependent on IL-12, whereas iNKT cell activation 
with a microbial antigen alone does not require IL-12.
iNKT cell activation during S. pneumoniae infection
Next, we examined the role of iNKT cells after infection 
with S. pneumoniae. Infection of WT and iNKT cell–deficient 
J18/ mice with S. pneumoniae showed reduced survival of 
iNKT cell–deficient J18/ mice (Fig. 7 A). Between days 6 
and 12 after infection, >50% of J18/ mice succumbed to 
infection, whereas none of the WT animals died. Similar re-
sults were obtained in CD1d-deficient animals (Fig. S8 A). 
Bacterial burden in lungs of infected WT or J18/ animals 
were comparable on day 3 after infection. However, on   
day 6 after infection, bacterial burden in lungs of J18/  
were 1,000-fold higher when compared with WT animals 
(Fig. 7 B). Thus, iNKT cells were critically important for protec-
tive immunity after pulmonary infection with S. pneumoniae.
To examine iNKT cell activation after pulmonary infec-
tion with S. pneumoniae, lymphocytes were isolated from lungs 
of infected and uninfected animals and iNKT cells were ana-
lyzed by flow cytometry for surface expression of the activa-
tion marker CD69 and for secretion of IFN-. Expression of 
CD69 was intermediate on iNKT cells from uninfected mice 
and increased on days 2, 4, and 7 after infection (Fig. 7 C). 
Figure 7.  In vivo activation of iNKT cells during S. pneumoniae in-
fection. WT or J18-deficient mice were infected intranasally with S. pneu-
moniae. (A) Survival was recorded daily for 2 wk for WT (filled squares;  
n = 9) and J18/ (open squares; n = 9) mice. Results are representative of 
two independent experiments. (B) The number of CFU was determined in 
lung tissues of WT (open bars; n = 6) or J18/ (filled bars; n = 6) on days 3 
and day 6 after infection. Data are pooled from two independent experi-
ments (mean ± SD). (C and D) Lymphocytes were isolated from lungs of 
mice infected intratracheally with S. pneumoniae or from uninfected mice 
and analyzed by flow cytometry. Staining for surface expression of CD69  
(C) or secreted IFN- or IL-4 (D) on CD1d tetramer–positive lymphocytes are 
shown. Data represent means ± SD (n = 6) and are pooled from two inde-
pendent experiments. (E and F) WT or IL-12p35–deficient mice were in-
fected intratracheally with S. pneumoniae and secretion of IFN- (E) or 
expression of CD69 by iNKT cells (F) was determined as described in C and  
D on day 2 after infection. Data represent means ± SD for three to four 
mice per group and one experiment of two similar experiments is shown.1172 Innate iNKT cell activation during infection | Brigl et al.
In comparison, much higher levels of IL-12R2 
mRNA were detected in NK cells. Interme-
diate levels of IL-12R2 were expressed by 
CD4+ and CD4 iNKT cells isolated from spleen, and high 
levels, similar to those detected on NK cells, were detected in 
CD4+ and CD4 liver iNKT cells. Second, we determined if 
the expression levels of IL-12R mRNA correlated with pro-
tein expression. Using CD1d tetramers to detect iNKT cells, 
we found that expression of IL-12R1 could be detected ex-
clusively on tetramer+/CD3+ lymphocytes (iNKT cells) but 
not on tetramer/CD3 lymphocytes (mainly NK cells) or 
tetramer/CD3+ (containing MHC-restricted CD4 and CD8 
T cells and T cells; Fig. 8 B).
The specific cellular effects of IL-12 are mainly a result of 
its ability to induce STAT4 activation. To determine if the 
constitutive expression of high levels of IL-12 receptor en-
abled prompt STAT4 activation in iNKT cells after IL-12 
stimulation, we purified naive and memory CD4 T cells, NK 
cells, and iNKT cells by cell sorting and stimulated the puri-
fied cell populations with IL-12 for 1 h. Intracellular phos-
phorylation of STAT4 was assessed by antibody staining and 
flow cytometry. No STAT4 phosphorylation was detected in 
naive and memory CD4 T cells (Fig. 8 C). In contrast, phos-
phorylation of STAT4 was detected in a large number of NK 
cells and iNKT cells. Thus, unique among T cells but similar 
(Fig. 7, E and F; and Fig. S8, B and C). Thus, most of the 
iNKT cell activation and IFN- production during S. pneu-
moniae infection in vivo was critically dependent on IL-12.
Expression and function of IL-12 receptor on iNKT cells
Responsiveness to IL-12 correlates with expression of IL-12 
receptor (IL-12R) on NK and activated T cells (Presky et al., 
1996; Trinchieri, 2003). To determine the expression of IL-12R 
by iNKT cells, we took complementary approaches. First, ex-
pression of mRNA for the two IL-12R subunits, IL-12R1 
and  IL-12R2,  was  determined  by  microarray  analysis  in 
iNKT cells and other lymphocyte subsets. IL-12R1, which 
is responsible for binding IL-12, was expressed at very low 
levels by naive CD4 and CD8 T cells, memory CD8 T cells, 
T cells, and NK cells, whereas slightly higher levels were 
detected in memory CD4 T cells (Fig. 8 A). In contrast, much 
higher levels of IL-12R1 mRNA were detected in both 
CD4+ and CD4 iNKT cells isolated from spleen or liver. 
IL-12R2, which is required for IL-12R–mediated signaling, 
was expressed at very low levels by naive CD4 and CD8 T cells, 
memory CD8 T cells, and T cells, whereas slightly higher 
levels were expressed by memory CD4 T cells (Fig. 8 A).   
Figure 8.  Expression and function of IL-12 recep-
tor on iNKT cells. (A) IL-12R1 (left) and IL-12R2 
(right) mRNA expression in purified splenocyte subsets 
or iNKT cell subsets purified from spleen or liver was 
assessed by microarray. Data are representative of two 
to four independent experiments and are shown as 
mean ± SD. (B) Flow cytometry staining of CD19 sple-
nocytes with CD1d tetramers and anti-CD3 antibodies 
(left). The tetramer/CD3 gate contains NK cells, the 
tetramer/CD3+ gate contains MHC-restricted CD4 and 
CD8 T cells and T cells, and the tetramer+/CD3+ 
gate contains iNKT cells. Surface expression of IL-12R1 
was determined by flow cytometry on gated lympho-
cyte subpopulations. (C) Naive and memory CD4 T cells, 
NK cells, and iNKT cells were isolated from spleens of 
WT mice and purified by cell sorting. Cells were stimu-
lated in the presence of 1 ng/ml recombinant IL-12 for 
1 h and subsequently stained with antibodies against 
the phosphorylated form of STAT4 (solid lines) or iso-
type control antibodies (dotted lines). (D) iNKT cell lines 
were incubated with WT (filled squares) or CD1d/ 
(open squares) DCs in the presence of various concen-
trations of recombinant IL-12. Data are presented as 
means of duplicate values ± SD and are representative 
of at least three independent experiments. (E) iNKT cell 
lines were incubated with WT DCs and various concen-
trations of the microbial lipid antigen GSL-1 in the ab-
sence or presence of various concentrations of 
recombinant IL-12. IFN- concentrations were mea-
sured in culture supernatants by ELISA after 16–24 h. 
Data are presented as means of triplicate values ± SD 
and are representative of two independent experiments.JEM Vol. 208, No. 6 
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iNKT cell activation and IFN- secretion in response to all 
microbes tested. Underscoring the critical and dominant role 
of IL-12 for rapid activation of iNKT cells, we detected 
that constitutive expression of high levels of IL-12R1 and 
IL-12R2 chains by iNKT cells and IL-12 stimulation rapidly 
led to STAT4 activation in iNKT cells. In contrast, MHC- 
restricted T cells lack constitutive expression of components 
of the IL-12 receptor and are only known to express func-
tional IL-12 receptor after activation and Th1 differentiation 
(Presky et al., 1996; Trinchieri, 2003). In agreement with pre-
vious studies, we found that naive and memory CD4+ T cells 
were not able to activate STAT4 after IL-12 stimulation in 
the  absence  of  additional  stimulation  or  differentiation. 
Recently, MAIT (mucosal-associated invariant T) lymphocytes, 
another lymphocyte population characterized by expression 
of an invariant TCR- chain, have been shown to become 
activated by microbes independently of TLR- and cytokine-
mediated stimulation, suggesting that these innate T cells require 
recognition of cognate microbial antigens for their activation 
(Le Bourhis et al., 2010). Thus, among T cells, iNKT cells   
to NK cells, high constitutive expression of functional IL-12 
receptor appears to provide a mechanistic explanation for the 
ability of iNKT cells to rapidly secrete IFN- in response to 
IL-12–mediated stimulation.
Last, we sought to address how IL-12–mediated co-
stimulation alters iNKT cell activation by CD1d-presented 
self- and microbial lipids. The addition of recombinant IL-12 
to iNKT cell lines cultured in the presence of WT DCs re-
sulted  in  notably  increased  IFN-  secretion,  as  compared 
with the addition of IL-12 to iNKT cell lines co-cultured in 
the presence of CD1d-deficient DCs (Fig. 8 D). As no exog-
enous antigens were added in this system, the stimulation pro-
vided by CD1d recognition was likely a result of recognition 
of CD1d-presented self-lipids. Next, we determined how co-
stimulation with IL-12 altered iNKT cell responses to micro-
bial antigens. A cross-titration of GSL-1 and IL-12 revealed 
that in particular low concentrations of GLS-1 and low con-
centrations of IL-12 resulted in a synergistic stimulation of 
IFN- by iNKT cells (Fig. 8 E). Thus, weak TCR-mediated 
stimulation of iNKT cells with CD1d-present self- or micro-
bial antigens was significantly amplified by IL-12, resulting in 
potent secretion of IFN- by iNKT cells.
DISCUSSION
iNKT cells have been shown to play important protective 
roles during several bacterial, parasitic, and viral infections. 
However, the central question of how they are activated by 
microbes is not fully explained. Because viruses lack lipid an-
tigens and antigens have only been described for a few patho-
gens so far, it is important to determine how many diverse 
pathogens can activate iNKT cells. To investigate the mecha-
nism of iNKT cell activation in response to infection, we used 
a large panel of diverse bacteria, including several that express 
known CD1d-presented iNKT cell lipid antigens. Unexpect-
edly, we found that, irrespective of the expression of CD1d-
presented lipid antigens by the microbes, microbe-induced 
iNKT cell activation and IFN- production in vitro and in 
vivo was critically dependent on IL-12 released by DCs after 
TLR-mediated activation. Thus, our data do not support a 
recently proposed model in which iNKT cell activation dur-
ing  infection  is  driven  by TCR-mediated  recognition  of 
CD1d-presented microbial antigens (Mattner et al., 2005; 
Tupin et al., 2007). Instead, our data suggest that innate cyto-
kine-driven activation is the dominant pathway for iNKT 
cell activation in response to virtually all infectious agents ex-
amined to date that induce the production of IL-12 by APCs 
after TLR-mediated activation (Fig. 9).
In addition to IL-12 as a critical mediator for stimulating 
iNKT cell responses to microbes, other studies have suggested 
a role for IL-18 and type I IFN in the iNKT cell response to 
E. coli LPS or the TLR9 agonist CpG, respectively (Nagarajan 
and Kronenberg, 2007; Paget et al., 2007). However, our in 
vitro experiments did not show a significant role for IL-18 or 
type I IFNs in response to any of the 11 bacterial pathogens 
tested. Instead, our in vitro and in vivo experiments repeat-
edly implicated IL-12 as the critical cytokine required for 
Figure 9.  Innate and cytokine-driven iNKT cell activation during 
microbial infection. iNKT cell activation during microbial infection is 
dominantly driven by innate TLR-mediated signals and IL-12, which is 
released by DCs after stimulation with microbial products. In addition, 
TCR-mediated stimulation contributes to iNKT cell activation. However, 
the TCR-mediated signal alone, provided either by recognition of CD1d-
presented self- or microbial antigens, is not sufficient to result in iNKT cell 
IFN- production in the absence of IL-12 stimulation. The constitutive 
expression of high levels of IL-12 receptor endows iNKT cells with the 
ability to respond rapidly to cytokine-mediated stimulation and ensures 
immediate iNKT cell activation in response to virtually any infectious 
agent that induces the production of IL-12, irrespective of the expression 
of microbial lipid antigens, thus allowing iNKT cells to overcome their 
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that induces IL-12 production, irrespective of the expression 
of iNKT cell ligands, and thus allows iNKT cells to overcome 
their restricted TCR repertoire and conserved mode of anti-
gen-recognition.  Such  a  mechanism  of  activation  may  be 
critical for iNKT cell responses to viral infection, because vi-
ruses are not known to encode enzymes for the production of 
unique microbial lipids, and for responses to other micro-
organisms that lack expression of CD1d-presented iNKT cell 
ligands. For the organisms that contain iNKT cell lipid anti-
gens, synthesis, uptake, and loading of antigens into CD1d 
molecules, and subsequent transport of antigen–CD1d com-
plexes to the surface of APCs, may be inefficient and slower 
than the IL-12–driven iNKT cell response.
The  rapid  innate  cytokine-driven  activation  of  iNKT 
cells provides the evolving immune response with T cell ef-
fector functions early during the course of infection that 
otherwise would only be available after the expansion and 
differentiation of antigen-specific MHC-restricted T cells 
(Brigl et al., 2003; Chiba et al., 2008). During infection, iNKT 
cell–secreted IFN- appears to serve several critically impor-
tant functions. This includes a critical role in activation of 
macrophages and in neutrophil-mediated clearance of patho-
gens (Nieuwenhuis et al., 2002; Nakamatsu et al., 2007). In addi-
tion, the early IFN- provided by iNKT cells has been shown 
to be critical for the development of adaptive Th1 immune 
responses and may affect the magnitude and quality of MHC-
restricted CD4 and CD8 T cell responses during infection 
(Tupin et al., 2007; Cohen et al., 2009). Together, iNKT cells, 
and the IFN- they produce, have emerged as critical regula-
tors of the early immune response during infection.
In summary, our findings indicate that during infection 
with a variety of bacterial pathogens, including bacteria which 
express known iNKT cell antigens, iNKT cell activation is 
driven predominantly by IL-12, rather than by TCR-mediated 
recognition of CD1d-presented microbial antigens (Fig. 9).   
In contrast to the dominant role observed for foreign antigen 
recognition in the activation of MHC-restricted T cells, the 
lack of dependence on specific recognition of cognate micro-
bial antigen defines a different role for the TCR in innate   
T cell activation. For the activation of iNKT cells during in-
fection,  CD1d–TCR  interactions  instead  appear  to  deter-
mine the cell–cell interaction between iNKT cells and APCs 
and allow T cell activation to become manifest. This may con-
trol such innate cytokine-driven activation so that it is local-
ized  to  sites  of  APC-produced  IL-12.  The  constitutive 
expression of high levels of IL-12 receptor uniquely equips 
iNKT cell for immediate cytokine-driven responses. Our   
results suggest a unified dominantly innate cytokine-driven 
model of iNKT cell activation that explains how these cells 
become activated efficiently and rapidly in response to highly 
diverse microbial pathogens.
MATERIALS AND METHODS
Mice. C57BL/6, IL-12p40/, IL-12p35/, and IL-18/ mice were ob-
tained from The Jackson Laboratory. J18/ (Cui et al., 1997) and CD1d/ 
mice  (Exley  et  al.,  2003)  were  provided  by  M.  Exley  (Harvard  Medical 
School, Boston, MA),  V14J18 TCR transgenic mice (Bendelac et al., 1996) 
appear to be uniquely equipped to promptly secrete IFN- 
upon primary encounter of an inflammatory condition that 
results in the production of IL-12.
Our in vitro experiments showed that full iNKT cell acti-
vation in response to all pathogens tested also required CD1d-
dependent signals and that increased expression of CD1d by 
bacteria-stimulated APCs may contribute to iNKT cell acti-
vation. However, in the absence of co-stimulation by IL-12, 
the  CD1d-mediated  signals  were  not  sufficient  to  induce 
IFN- secretion by iNKT cells. Our in vitro studies showed 
that iNKT cell responses to weak self-antigens or to low con-
centrations of microbial antigen were amplified by exoge-
nously added IL-12. Therefore, although not able to activate 
iNKT cells through TCR-mediated signaling alone, it seems 
likely that even small numbers of CD1d–microbial antigen 
complexes or presentation of more potent self-antigens may 
contribute to or modulate iNKT cell activation during infec-
tion in the presence of IL-12–mediated co-stimulation. Fur-
thermore, the requirement for CD1d-TCR–mediated signals 
may ensure that IL-12–amplified iNKT cell activation occurs 
only in close contact with CD1d-expressing APCs such as 
monocytes, DCs, macrophages, and B cells. The lack of de-
pendence on specific recognition of CD1d-presented micro-
bial antigens found in this study suggests that the exceptional 
potency of the pharmacological iNKT cell agonist -GalCer, 
which is much greater than that of any naturally occurring iNKT 
cell antigen found to date, may have led to overestimation of the 
importance of microbial antigens in iNKT cell activation.
iNKT cell responses to all of the microbial antigens de-
scribed so far result in the production of both IFN- and IL-4 
by iNKT cells both in vitro and in vivo. Most of the bacteria 
tested in our studies resulted in a bias toward production of 
IFN-, using iNKT cell lines, freshly isolated iNKT cells, and 
during in vivo infection. Interestingly, the occasionally ob-
served IL-4 induced by Sphingomonas spp. in vitro was in-
creased in the absence of IL-12, suggesting that IL-12 may 
play an important role in polarizing iNKT cell responses to 
infection. However, in vivo infection with Sphingomonas spp. 
in IL-12–deficient mice did not result in a notable increase in 
the number of iNKT cells producing IL-4 (unpublished data). 
Stimulation of iNKT cells with B. burgdorferi resulted in IL-4 
production by iNKT cells in our studies, which is consistent 
with previous studies detecting IL-4 production by a small 
number of iNKT cells in spleen after B. burgdorferi infection 
(Tupin et al., 2008). The in vitro IL-4 production observed in 
our studies appeared to be IL-12 independent but MyD88 
dependent, suggesting that innate signals, rather than micro-
bial antigens, are responsible for the iNKT cell IL-4 produc-
tion in response to this bacterium. Further studies will be 
required to understand the nature of the signals responsible 
for bacteria-induced IL-4 production by iNKT cells.
Activation of iNKT cells during infection driven by in-
nate  signals  and  cytokines,  rather  than  microbial  antigens, 
provides several advantages. As an amplification loop for in-
nate signals, cytokine-mediated activation enables the activa-
tion of iNKT cells in response to virtually any microorganism JEM Vol. 208, No. 6 
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leave a minimal residual abundance of precursor ion (around 10%). Mass spec-
tra were accumulated in the profile mode, typically for 3–10 min for MSn (n = 
2, 3, and 4) spectra. The mass resolution of the instrument was tuned to 0.6 D 
at half peak height. Synthetic GSL-1 was provided by the NIH tetramer facility 
and P.B. Savage (Brigham Young University, Provo, UT; Mattner et al., 2005). 
Synthesis of -GalCer has been previously described (Veerapen et al., 2009).
In vitro infections. Bacteria were grown to mid-log phase, as described in 
Bacteria, and added to DCs cultured in antibiotic-free complete RPMI. After 
a 3-h incubation at 37°C, infected DCs were washed 3× in complete RPMI. 
Infected DCs (5 × 104/well) were co-cultured with iNKT cell lines (105/
well) in complete RPMI medium in 96-well plates for 16–24 h.
In vivo infection and flow cytometry. S. pneumoniae was grown as de-
scribed in Bacteria and mice were anesthetized with i.p. ketamine/xylazine 
or by inhalation isoflurane and inoculated intranasally or intratracheally, re-
spectively, with 2–3 × 106 bacteria in PBS. CFUs were determined on blood 
agar plates. For flow cytometric analysis, mononuclear cells were isolated 
from lungs perfused with PBS followed by digestion with collagenase/DNase. 
S. yanoikuyae was grown in TSB supplemented with 5% sheep blood and pas-
saged in SCID mice. Mice were injected i.v. with 4 × 109 bacteria in 200 µl 
PBS.  Cells  were  stained  with  antibodies  against  CD45,  CD19, TCR-, 
PBS57-loaded CD1d tetramers (NIH Tetramer Core Facility), CD69, or iso-
type-matched control antibodies. Secretion of IFN- or IL-4 was determined by 
cytokine secretion assay (Miltenyi Biotec) according to the manufacturer’s in-
structions. Flow cytometric data were collected on a LSR II flow cytometer 
(BD) and analyzed with FlowJo software (Tree Star).
IL-12 receptor expression. iNKT cells were purified from spleen or liver 
on a MoFlo cell sorter (Dako) gating on CD19, B220, Ter119, CD11b, 
CD11c, LyG/Gr-1, CD45+, TCRint, CD1d-tetramer+, CD4+, or CD4 
iNKT cells, followed by RNA extraction with Trizol (Invitrogen), RNA ampli-
fied, and hybridized to Affymetrix 1.0 ST MuGene arrays within the NI-
AID/NIH ImmGen project (protocols and raw data available at http://www 
.immgen.org; Heng and Painter, 2008). For flow cytometric analysis, cells 
were stained with CD1d tetramers and antibodies against IL-12R1 (BD).
STAT4  phosphorylation.  Naive  (CD62LhiCD44lo)  and  memory 
(CD62LloCD44hi) TCR+CD4+ T cells, NK cells (NK1.1+TCR-), and 
iNKT cells (as in the previous section) were isolated by negative selection 
and cell sorting. 1–5 × 105 purified cells were cultured in completed RPMI 
and stimulated with recombinant IL-12 for 1 h at 37°C and subsequently stained 
with antibodies against pSTAT4 (BD) according to manufacturer’s protocols.
Online supplemental material. Fig. S1 shows mass spectrometry analysis 
of microbial lipids separated by liquid chromatography. Fig. S2 shows repre-
sentative dose titrations for bar graphs depicted in Fig. 4 (A and C). Fig. S3 
shows IL-18 and type I IFN independence of iNKT cell activation in response 
to microbes. Fig. S4 shows representative FACS plots for bar graphs depicted 
in Fig. 4 D. Fig. S5 shows IL-12 dependence of IFN- secretion and CD25 
expression by iNKT cells on day 2 after activation with microbial products. 
Fig. S6 shows cytokine responses to microbial stimulation of freshly isolated 
iNKT cells. Fig. S7 shows MyD88-dependent CD1d expression by DCs after 
stimulation with microbial products. Fig. S8 shows survival of  WT and CD1d-
deficient mice after S. pneumoniae infection and in vivo activation of iNKT 
cells on day 4 after S. pneumoniae infection. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20102555/DC1.
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by A. Bendelac (University of Chicago, Chicago, IL), and MyD88/ (Adachi 
et al., 1998) by K. Kobayashi (Harvard Medical School, Boston, MA). All 
mice were on the C57BL/6 background, were housed in specific pathogen-
free conditions or a biosafety level 2 animal facility after in vivo infections, 
and female mice at 6–14 wk of age were used for experiments. All animal 
studies were approved by the Dana-Faber Cancer Institute Animal Care and 
Use Committee.
In vitro iNKT cell assay. iNKT cell lines were generated and maintained 
in complete RPMI medium (RPMI supplemented with 10% FBS [Gemini], 
Hepes [Invitrogen], L-glutamine, penicillin/streptomycin, and 2-ME) sup-
plemented  with  20  U/ml  of  recombinant  mouse  IL-2  (PeproTech)  and   
10 ng/ml IL-7 as previously described (Chiba et al., 2009). DCs were generated 
from BM of mice cultured in complete RPMI supplemented with 10 ng/ml 
of recombinant mouse GM-CSF and 1 ng/ml IL-4 for 5–8 d and purified 
with CD11c magnetic beads (Miltenyi Biotec). iNKT cell lines (105/well) 
were cultured with DCs (2 × 104/well) in 96-well plates (Costar; Corning) 
in complete RPMI. Freshly isolated iNKT cells were obtained from spleens 
of WT B6 animals after depletion of CD19+ and CD8a+ cells using magnetic 
beads (Miltenyi Biotec), followed by cell sorting using CD1d tetramers and 
TCR- staining on a FACSAria IIu instrument (BD). GSL-1 (National In-
stitutes of Health [NIH] Tetramer Core Facility), LPS (Salmonella enterica  
serotype Typhimurium; Sigma-Aldrich), CpG (ODN1826; InvivoGen),   
recombinant mouse IL-12 (PeproTech), or bacteria were added and cultures 
were incubated for 16–48 h at 37°C. Culture supernatants were analyzed by 
ELISA with matched antibody pairs (IFN- and IL-4 [BD], sensitivity 10 
and 2 pg/ml, respectively; IL-18 and IFN- [R&D Systems]). Blocking anti–
IL-12 (BD) and anti–mouse IFN-/ R1 antibodies (R&D Systems) were 
added to cultures at 5–10 µg/ml. Expression of CD25 was determined on 
iNKT cells by flow cytometry (gated by FSC/SSC). Surface expression of 
CD1d on CD11c+ BM DCs was determined using CD1d Abs (BD) after in-
cubation with various stimuli.
Bacteria. S. pneumoniae (for strains and references see Table I; provided by   
K. Kawakami (University of the Ryukyus, Nishihara, Okinawa, Japan), cultured 
in THY [BD] or BHI [Oxoid] medium), L. monocytogenes (BHI medium),   
S. aureus (LB medium; BD), P . aeruginosa (LB medium, provided by R. Blum-
berg, Harvard Medical School, Boston, MA), S. typhimurium (LB medium),   
E. coli (LB medium), S. capsulata (MH medium, 30°C; Oxoid), N. aromaticiv-
orans (MH medium), S. yanoikuyae (TSB), and B. burgdorferi (BSK-H medium, 
33°C; provided by L. Bockenstedt,  Yale School of Medicine, New Haven, CT; 
Sigma-Aldrich) were grown in culture medium at 37°C, unless otherwise 
noted, until mid- to late-log phase, washed 3× in LPS-free PBS (Invitrogen), 
and heat inactivated at 65°C for 45 min. B. burgdorferi were inactivated at 
48°C for 30 min. M. tuberculosis were inactivated by  radiation (Colorado 
State University, Fort Collins, CO). All bacterial preparations, except gram-
negative bacteria, tested negative for LPS by Limulus amebocyte lysate test 
(limit of detection 0.03 EU/ml; Associates of Cape Cod).
Lipids, lipid extraction, and MS analysis. Lipids were extracted and ana-
lyzed by thin layer chromatography, as described elsewhere (Tatituri et al., 
2007), or analyzed by high performance liquid chromatography (HPLC)   
using a AutoPurification HPLC system coupled to a mass detector with both 
ES and APCI capabilities, evaporative light scattering detector, and photo-
diode array detector (Waters). MS analysis, including low-energy CAD MSn   
experiments, were conducted on a linear ion-trap (LIT) mass spectrometer 
(Finnigan; Thermo Fisher Scientific) with Xcalibur operating system. Lipid 
extracts dissolved in chloroform/methanol (1/2) were continuously infused 
(2 µl/min) to the ESI source, where the skimmer was set at ground potential, 
the electrospray needle was set at 4.5 kV, and temperature of the heated capil-
lary was 300°C. The automatic gain control of the ion trap was set to 2 × 104, 
with a maximum injection time of 100 ms. Helium was used as the buffer and 
collision gas at a pressure of 103 mbar (0.75 mTorr). The MSn experiments 
were performed with an optimized relative collision energy ranging from   
18–25%, an activation q value at 0.25, and the activation time at 30–50 ms to 1176 Innate iNKT cell activation during infection | Brigl et al.
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